Genetics and pathogenesis of multiple sclerosis

Seminars in Immunology

Volumn 21, Issue 6, 2009, Pages 328-333

  Zuvich, R L ^a   McCauley, J L ^b   Pericak Vance, M A ^b   Haines, J L ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Multiple sclerosis

Indexed keywords

HLA DR2 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR ALPHA;

CEREBROSPINAL FLUID ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; HERITABILITY; HUMAN; IMMUNOPATHOLOGY; INCIDENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR;

ANIMALS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MULTIPLE SCLEROSIS;

EID: 70749151948     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2009.08.003     Document Type: Review

References (48)

1. Compston A., and Coles A. Multiple sclerosis. Lancet 359 9313 (2002) 1221-1231
2. Kutzelnigg A., Lucchinetti C.F., Stadelmann C., Brück W., Rauschka H., Bergmann M., et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128 Pt 11 (2005) 2705-2712
3. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N Engl J Med 343 13 (2000) 938-952
4. Confavreux C., Vukusic S., Moreau T., and Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 343 20 (2000) 1430-1438
5. Trapp B.D., and Nave K.A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu Rev Neurosci 31 (2008) 247-269
6. Ascherio A., and Munger K.L. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61 4 (2007) 288-299
7. Kantarci O., and Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr Opin Neurol 19 3 (2006) 248-254
8. Ebers G.C. Environmental factors and multiple sclerosis. Lancet Neurol 7 3 (2008) 268-277
9. Cantorna M.T. Vitamin D and multiple sclerosis: an update. Nutr Rev 66 10 Suppl. 2 (2008) S135-S138
10. Hauser S.L., and Goodkin D.E. Multiple sclerosis and other demyelinating diseases. In: Fauci A.D., Braunwald E., Isselbacher J.D., Martin J.B., Kasper D.L., Hauser S.L., et al. (Eds). Harrison's principle of internal medicine (1998), McGraw Hill, New York 2409-2419
11. Alonso A., Jick S.S., Olek M.J., Ascherio A., Jick H., and Hernán M.A. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 62 9 (2005) 1362-1365
12. Sundstrom P., Nystrom L., and Hallmans G. Smoke exposure increases the risk for multiple sclerosis. Eur J Neurol 15 6 (2008) 579-583
13. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 3 (1983) 227-231
14. Goodkin D.E., Doolittle T.H., Hauser S.S., Ransohoff R.M., Roses A.D., and Rudick R.A. Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch Neurol 48 8 (1991) 805-807
15. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 1 (2001) 121-127
16. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 11 (1983) 1444-1452
17. Roxburgh R.H., Seaman S.R., Masterman T., Hensiek A.E., Sawcer S.J., Vukusic S., et al. Multiple sclerosis severity score: using disability and disease duration to rate disease severity. Neurology 64 7 (2005) 1144-1151
18. Mumford C.J., Wood N.W., Kellar-Wood H., Thorpe J.W., Miller D.H., and Compston D.A. The British Isles survey of multiple sclerosis in twins. Neurology 44 11 (1994) 15
19. Sadovnick A.D., and Ebers G.C. A population based study of multiple sclerosis in twins: update. Ann Neurol 33 (1993) 281-285
20. Sadovnick A.D., and Ebers G.C. Genetics of multiple sclerosis. Neurol Clin 13 (1995) 99-118
21. Batchelor J.R., Compston A., and McDonald W.I. The significance of the association between HLA and multiple sclerosis. Br Med Bull 34 3 (1978) 279-284
22. Bertrams J., and Kuwert E. HL-A antigen frequencies in multiple sclerosis. Significant increase of HL-A3, HL-A10 and W5, and decrease of HL-A12. Eur J Neurol 7 74 (1972) 78
23. Naito S., Namerow N., Mickey M.R., and Terasaki P.I. Multiple sclerosis: association with HL-A3. Tissue Antigens 2 1 (1972) 1-4
24. Dyment D.A., Ebers G.C., and Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 3 2 (2004) 104-110
25. Haines J.L., Terwedow H.A., Burgess K., Pericak-Vance M.A., Rimmler J.B., Martin E.R., et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group. Hum Mol Genet 7 8 (1998) 1229-1234
26. Sawcer S. The complex genetics of multiple sclerosis: pitfalls and prospects. Brain (2008)
27. Barcellos L.F., Sawcer S., Ramsay P.P., Baranzini S.E., Thomson G., Briggs F., et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 15 18 (2006) 2813-2824
28. Chao M.J., Barnardo M.C., Lincoln M.R., Ramagopalan S.V., Herrera B.M., Dyment D.A., et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci USA 105 35 (2008) 13069-13074
29. Yeo T.W., De Jager P.L., Gregory S.G., Barcellos L.F., Walton A., Goris A., et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 61 3 (2007) 228-236
30. Oksenberg J.R., and Barcellos L.F. Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 6 5 (2005) 375-387
31. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., et al. A full genome search in multiple sclerosis. Nat Genet 13 4 (1996) 472-476
32. Haines J.L., Ter-Minassian M., Bazyk A., Gusella J.F., Kim D.J., Terwedow H., et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13 4 (1996) 469-471
33. Kuokkanen S., Gschwend M., Rioux J.D., Daly M.J., Terwilliger J.D., Tienari P.J., et al. Genomwide scan of multiple sclerosis Finnish multiplex families. Am J Hum Genet 61 (1997) 1379-1387
34. Sawcer S., Jones H.B., Feakes R., Gray J., Smaldon N., Chataway J., et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genetics 13 (1996) 464-468
35. Transatlantic Multiple Sclerosis Genetics Cooperative. A meta-analysis of genomic screens in multiple sclerosis. Mult Scler 7 1 (2001) 3-11
36. Kenealy S.J., Babron M.C., Bradford Y., Schnetz-Boutaud N., Haines J.L., Rimmler J.B., et al. A second-generation genomic screen for multiple sclerosis. Am J Hum Genet 75 6 (2004) 1070-1078
37. Kenealy S.J., Herrel L.A., Bradford Y., Schnetz-Boutaud N., Oksenberg J.R., Hauser S.L., et al. Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44. Genes Immun 7 1 (2006) 73-76
38. International Multiple Sclerosis Genetics Consortium (2005) A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 77:454-467.
39. Oksenberg J.R., Baranzini S.E., Sawcer S., and Hauser S.L. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet 9 7 (2008) 516-526
40. Hauser M.A., Li Y.J., Takeuchi S., Walters R., Noureddine M., Maready M., et al. Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. Hum Mol Genet 12 6 (2003) 671-677
41. Gregory S.G., Schmidt S., Seth P., Oksenberg J.R., Hart J., Prokop A., et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet (2007)
42. International Multiple Sclerosis Genetics Consortium. The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 10 1 (2009) 11-14
43. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet 69 1 (2001) 124-137
44. Reich D.E., and Lander E.S. On the allelic spectrum of human disease. Trends Genet 17 9 (2001) 502-510
45. Smith D.J., and Lusis A.J. The allelic structure of common disease. Hum Mol Genet 11 20 (2002) 2455-2461
46. Wang W.Y., Barratt B.J., Clayton D.G., and Todd J.A. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet 6 2 (2005) 109-118
47. Hirschhorn J.N., Lohmueller K., Byrne E., and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 4 2 (2002) 45-61
48. Moore J.H. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 56 1-3 (2003) 73-82